The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This federal Project Grant award, with an obligated amount of $361,679.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will support research conducted by the University of Connecticut to develop dual-function biomaterials for the treatment of interstitial cystitis. The research aims to transform healthcare for military service members and the broader public by pursuing innovative solutions to critical medical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $435,465.00 to the University of Connecticut Health Center (UCHC) to conduct research on the use of acoustic radiation force and cell therapy to heal large-scale cranial defects. The project will run from February 1, 2025 to January 31, 2027. As part of this effort, UCHC will collaborate with the Connecticut Children's Medical Center, which will...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Connecticut received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 15, 2025, with a completion date of August 14, 2027, supports research aimed at "Enhancing Inflammation-Repressive Function of the Lupus Susceptibility Protein TNIP1". This project-based grant contributes to the program's broader objective of transforming healthcare for military...
This $749,822 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to develop transformative multistaged treatment approaches for composite tissue injuries. The research aims to transform healthcare for military service members, veterans, and the broader public. The award has a performance period from...
This Project Grant award of $172,355 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Connecticut Health Center to investigate spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes, with the goal of enhancing melanoma therapeutics. The research aims to chart a path for improved treatment of melanoma by mapping changes in gene expression and protein levels within immune cells...
The University of Connecticut Health Center (UCHC) received a $1,182,528 Project Grant award from the Defense Health Agency to develop a multifunctional bandage lens and bioadhesive for the treatment of corneal wounds. This award, which runs from September 1, 2023 to August 31, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCHC's research to transform health care for Service Members and the American public through innovative and...
This Project Grant award, with a total funding of $5,963,305.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the continued clinical development of a novel pleural and tracheal sealant. The primary award recipient is the University of Vermont & State Agricultural College. A sub-award of an unspecified amount was provided to the University of Connecticut Health Center to support this research effort. The funding will...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...